发明名称 |
METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION |
摘要 |
Provided herein are methods and kits related to use of vanin-1 (VNN1) expression for assessing responsiveness to steroid treatment in subjects with asthma and for treating subjects with asthma. |
申请公布号 |
US2017088896(A1) |
申请公布日期 |
2017.03.30 |
申请号 |
US201515311737 |
申请日期 |
2015.05.15 |
申请人 |
Children's Hospital Medical Center d/b/a Cincinnati Children's Hospital Medical Center |
发明人 |
Hershey Gurjit Khurana;Myers Jocelyn Biagini;Ji Hong;Martin Lisa J. |
分类号 |
C12Q1/68;A61K31/215;A61K31/145;A61K9/00;G01N33/68;A61K31/573 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of assessing responsiveness to a steroid treatment of asthma in a subject, the method comprising:
(a) measuring a level of Vanin 1 (VNN1) expression in a biological sample obtained from a subject having asthma, suspected of having asthma, or at risk for asthma; and (b) assessing the subject's responsiveness to the steroid treatment based on the level of VNN1 expression, wherein a decreased level of VNN1 expression relative to a pre-determined value indicates that the subject is not responsive or not likely to respond to the steroid treatment, and wherein a same or elevated level of VNN1 expression relative to the pre-determined value indicates that the subject is responsive or likely to respond to the steroid treatment. |
地址 |
Cincinnati OH US |